Article Information
History
- August 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Steffanie A. Strathdee1,*,
- Daniela Abramovitz1,
- Alicia Harvey-Vera1,2,4,
- Carlos Vera1,
- Gudelia Rangel3,4,
- Irina Artamonova1,
- Antoine Chaillon1,
- Caroline Ignacio5,
- Alheli Calderon1,6,
- Natasha K. Martin1 and
- Thomas L. Patterson7
- 1Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, United States of America
- 2Universidad Xochicalco, Facultad de Medicina, Campus Tijuana, Mexico
- 3Departmento de Estudios de Población, El Colegio de la Frontera Norte, Tijuana, Mexico
- 4United States-Mexico Border Health Commission, Tijuana, Mexico
- 5CFAR Translational Virology Core, Department of Medicine, University of California San Diego, La Jolla, CA, United States of America
- 6School of Public Health, San Diego State University, San Diego, California, United States of America
- 7Department of Psychiatry, University of California, San Diego, La Jolla, CA, United States of America
- ↵*Corresponding Author: E-mail: sstrathdee{at}health.ucsd.edu
Posted August 07, 2021.
Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region
